Antimycin A1 10360 Smiles: CC(C)(C)[C@@H]1NC(=O)OCC(C)(C)CCCCC2=CC=CC3CN(CC2=3)C(=O)O[C@@H]2C[C@@H](C(=O)N[C@@]3(C[C@H]3CC)C(=O)NS(=O)(=O)C3CC3)N(C2)C1=O

Smiles: CC(C)(C)[C@@H]1NC(=O)OCC(C)(C)CCCCC2=CC=CC3CN(CC2=3)C(=O)O[C@@H]2C[C@@H](C(=O)N[C@@]3(C[C@H]3CC)C(=O)NS(=O)(=O)C3CC3)N(C2)C1=O

Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis

toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer

InChi: InChI=1S/C8H8O3/c9-7(8(10)11)6-4-2-1-3-5-6/h1-5

2005 Mar 18

Antimycin A1 10360 Smiles: CC(C)(C)[C@@H]1NC(=O)OCC(C)(C)CCCCC2=CC=CC3CN(CC2=3)C(=O)O[C@@H]2C[C@@H](C(=O)N[C@@]3(C[C@H]3CC)C(=O)NS(=O)(=O)C3CC3)N(C2)C1=OAntimycin A1 is a specific electron transfer inhibitor of ubiquinol cytochrome c oxidoreductase. Antimycin A1 inhibits angiogenesis through decrease in VEGF production caused by inhibition of HIF 1 activation. Product information CAS Number: 642 15 9 Molecular Weight: 548. 63 Formula: C28H40N2O9 Chemical Name: (2R,3S,6S,7R,8R) 3 (3 formamido 2 hydroxybenzamido) 8 hexyl 2,6 dimethyl 4,9 dioxo 1,5 dioxonan 7 yl 3 methylbutanoate Smiles: